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Abstract
Background. There is evidence for the cost-effectiveness of health visitor (HV) training to
assess postnatal depression (PND) and deliver psychological approaches to women at risk
of depression. Whether this approach is cost-effective for lower-risk women is unknown.
There is a need to know the cost of HV-delivered universal provision, and how much it
might cost to improve health-related quality of life for postnatal women. A sub-study of a clus-
ter-randomised controlled trial in the former Trent region (England) previously investigated
the effectiveness of PoNDER HV training in mothers at lower risk of PND. We conducted a
parallel cost-effectiveness analysis at 6-months postnatal for all mothers with lower-risk status
attributed to an Edinburgh Postnatal Depression Scale (EPDS) score <12 at 6-weeks postnatal.
Methods. Intervention HVs were trained in assessment and cognitive behavioural or person-
centred psychological support techniques to prevent depression. Outcomes examined: quality-
adjusted life-year (QALY) gains over the period between 6 weeks and 6 months derived from
SF-6D (from SF-36); risk-of-depression at 6 months (dichotomising 6-month EPDS scores
into lower risk (<12) and at-risk (⩾12).
Results. In lower-risk women, 1474 intervention (63 clusters) and 767 control participants
(37 clusters) had valid 6-week and 6-month EPDS scores. Costs and outcomes data were avail-
able for 1459 participants. 6-month adjusted costs were £82 lower in intervention than control
groups, with 0.002 additional QALY gained. The probability of cost-effectiveness at £20 000
was very high (99%).
Conclusions. PoNDER HV training was highly cost-effective in preventing symptoms of PND
in a population of lower-risk women and cost-reducing over 6 months.
Introduction
One in five women may experience perinatal mental illness (Gavin et al., 2005). Opportunities
to diagnose these conditions may be missed by primary care physicians (Prady et al., 2016;
Ford et al., 2017) and, in particular, half of all cases of perinatal depression (prevalence of
one in eight women) go undetected (Gavin et al., 2015; Bauer et al., 2016b). Consequences
of untreated postnatal depression (PND) can be profound and long-lasting for women and
families, with risks of longer-term adverse effects on child development and associated costs
(Bauer et al., 2016b), yet there are psychosocial treatments that a growing evidence base sug-
gests are effective (Milgrom and Gemmill, 2014; Morrell et al., 2016).
Health visitors (HVs) are public health nurses, based in community settings such as health
centres and family centres across the UK, playing important roles in supporting women during
and after pregnancy (Cowley et al., 2007, 2013; Health Education England, 2016). The impact
of PoNDER HV training in assessment and delivery of cognitive-behavioural and person-
centred approaches (CBA and PCA) in terms of effectiveness and cost-effectiveness for
women and children has been reported (Morrell et al., 2009a). PoNDER HV training can
reduce the proportion of women at risk of developing PND as indicated by a reduction in
score on the Edinburgh Postnatal Depression Scale (EPDS) (Cox et al., 1987), a self-report
measure widely used in clinical practice (Hewitt and Gilbody, 2009). Scores on the 10-item
EPDS range from 0 to 30, higher scores indicating more depressive symptoms; at-risk
women were identified as those scoring 12 or more.
Further analyses of mental health outcomes in the subgroup of lower-risk women (EPDS
score < 12) in the PoNDER trial at 6 weeks after childbirth suggested that participants in
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the intervention group had a reduced risk of developing PND as
indicated by reduction in EPDS scores 6 months after childbirth
(Brugha et al., 2011). While the training intervention appeared
to be effective, that analysis did not address the separate question
of costs and cost-effectiveness. There is a need to know whether
the additional costs associated with providing this additional
care are considered worthwhile in relation to the health benefit
it produces. Here we examine the cost-effectiveness of this univer-
sal preventive approach for lower-risk women.
Method
The main PoNDER cluster-randomised controlled trial is detailed
elsewhere (Morrell et al., 2009b, 2009a). The trial randomised 101
general practitioner (GP) practices to either (a) ‘usual health vis-
itor care’ (n = 38 clusters; 1 cluster lost to follow-up); (b) care by
HVs trained in assessing postnatal for symptoms of PND and a
CBA to address postnatal psychological problems (n = 30 clus-
ters); or (c) care by HVs trained in assessing women for symp-
toms of PND and a PCA to address postnatal psychological
problems (n = 32 clusters). HVs received brief training derived
from CBT principles (Appleby et al., 1997) for the CBA arm or
from person-centred counselling principles (Holden et al.,
1989), for the PCA arm (Morrell et al., 2011). The training was
carried out by Masters-level trainers and was equivalent for
both the CBA and PCA arms (1 day on clinical assessment skills;
5 days on psychotherapeutic approach; 4 half days of reflective
practice/clinical supervision). The training developed intervention
HVs’ skills in genuineness and listening so that HVs could talk to
the woman about PND, gain her trust, develop an ongoing rela-
tionship with her, and be open to being re-contacted if the
woman felt that her symptoms were not improving spontan-
eously. We recognised that the research was undertaken in a
population that could be considered to be a vulnerable group
and so the trial excluded: women under 18 and women with pre-
existing severe and enduring mental health problems. The trial
began in April 2003 and continued over 3 years. Baseline mea-
surements, including EPDS, were taken at 6 weeks postnatally.
Women completed study questionnaires at 6, 12, and 18 months
postnatally. In all, 4084 women consented to participate in the
study; 3449 returned baseline 6-week postal questionnaires, of
whom 595 (17.3%) scored 12 or more on EPDS (‘at-risk’
women). At-risk women in intervention groups (b) and (c)
were offered up to 8 weekly psychologically informed sessions
with the HV. Brugha et al. (2011) subsequently reported a
sub-study of the main trial, focused on lower-risk participants
who scored below 12 on the 6-week postnatal EPDS (‘EPDS-
negative’) (further information, including trial CONSORT dia-
gram and cluster-randomisation methods can be found in that
publication). The study examined the effectiveness of care from
HVs trained in assessment and psychological support in prevent-
ing PND in EPDS-negative women 6–18 months later.
Economic evaluation
The economic evaluation examined the cost-effectiveness of
PoNDER HV training for PND in the population of lower-risk
(EPDS-negative) women examined in the Brugha et al. (2011)
sub-study. We also explored whether PoNDER training affected
the number of HV visits and whether the impact was similar
across women with different levels of depression risk. The eco-
nomic evaluation design followed technology appraisal guidelines
by the National Institute for Clinical Excellence (2004) (NICE)
(now National Institute for Health and Care Excellence) and con-
sequently took an NHS and social care perspective.
Costs
The following costs were included: HV training and ongoing clin-
ical supervision to deliver the intervention; HV contacts (number,
duration and purpose of visit – whether for PND, mother
(excluding PND), baby or any combination of the three); infant
immunisations; GP contacts; prescriptions for all conditions;
social worker contacts; admissions to Mother and Baby psychi-
atric units; other mental health contacts, including counsellor,
community psychiatric nurse (CPN), community mental health
team (CMHT); mental health nurse (MHN), crisis services,
psychologist, psychotherapist, psychiatric outpatient and mother
and baby psychiatric outpatient.
Cost components (Table 1) other than costs of delivering the
intervention were derived from resource use data and nationally
representative unit costs applicable at the time the trial started
[principally Netten and Curtis (2004)]. Resource use data from
6 weeks to 6 months were collected on a resource use log com-
pleted by HVs based on their own and GP records (Morrell
et al., 2009b).
The costs of delivering PoNDER training were calculated from
trainer fees, travel, backfill HV time and ongoing clinical supervi-
sion costs (Morrell et al., 2009b). Mean cost of training per HV
was £1398 (annual equivalent £988). This translated to an
increase in cost per HV hour of client time from £77 (Netten
and Curtis, 2004) to £79: these figures represent unit costs used
for HVs in control and intervention groups, respectively.
Outcomes
Data on health-related quality of life were collected using SF-36 at
6 weeks, 6 and 12 months, and generated the preference-based
health measure, the SF-6D index (Brazier et al., 2002). Mothers’
quality-adjusted life-year (QALY) gains between 6 weeks and 6
months were calculated from SF-6D utility index scores at those
time points by the area-under-the-curve using the trapezoidal
method (Manca et al., 2005a). We examined risk-of-depression
outcomes at follow-up as a secondary outcome, dichotomis-
ing 6-month EPDS scores into 1 = lower-risk (score < 12) and
0 = at-risk (score⩾ 12).
Analysis
Cluster-adjusted t tests were applied to comparisons of continu-
ous data; cluster-adjusted chi-squared tests were applied to tabu-
lations of categorical data (Davis, 2001; Herrin, 2012).
Intra-cluster correlation coefficients (ICCs) were derived from
one-way analysis of variance (Ukoumunne, 2002). The conven-
tional 5% level of significance was used throughout.
In addition to cost-effectiveness analyses, we explored whether
the PoNDER HV training affected the number of HV visits and
whether the impact varied by level of depression risk. We
addressed the latter question by examining whether numbers of
HV visits over the 6-month follow-up differed according to the
proximity of participants’ scores to the threshold for ‘lower-risk’
v. ‘at-risk women’. The sample was differentiated into risk sub-
groups of ‘very low risk’, ‘subthreshold risk’ and ‘at-risk’ women
(EPDS score 0–5; 6–11; and 12 or more, respectively) adopting
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cut-points used previously (Brugha et al., 2011) for the effective-
ness analysis. A two-level negative binomial model of HV visits
was fitted to examine impacts of PoNDER training on visits across
all low-risk participants, controlling for experimental group, rea-
son for visit (for mother, baby and/or PND), number of children,
history of serious life-events and (for reasons discussed below)
cluster size and treatment × cluster size interaction. The model
was then extended to include risk sub-group (very low risk v. sub-
threshold risk) and its interaction with the experimental group.
Analysis of cluster-randomised data must consider correlations
between observations within clusters to avoid biased estimates of
sampling uncertainty and imprecision in estimating coefficients
(Manca et al., 2005b). HVs and GPs working within the general
practice and the women registered there comprised a cluster.
Clustering effects can arise because a practice’s patients might
have characteristics in common (e.g. similar reasons for living
within the practice area, socio-economic circumstances).
Clustering may affect costs and outcomes differently, and ICCs
of costs may be larger than those of outcomes (Gomes et al.,
2012a). There may be differential recruitment to and attrition
from clusters between trial arms (Adams et al., 2004).
Imbalances in cluster size between experimental groups could
be related to the outcome being measured; for example, the vol-
ume of work undertaken by practitioners may be related to
patient outcomes (Panageas et al., 2007; Gomes et al., 2012a).
Because of its cluster-randomised design, the PoNDER trial
dataset (all levels of risk of PND) has previously served as the
basis for exploring approaches to economic modelling of clustered
data (Gomes et al., 2012b). We applied recommended methods
(Gomes et al., 2012b) to all lower-risk participants (EPDS
score<12), considering effects of clustering on estimated coeffi-
cients and standard errors of costs and outcomes while addressing
potential correlations between them (Gomes et al., 2012a). In our
base-case analysis, we used a system of equations (seemingly-
unrelated regressions, SUR) where costs and outcomes error
terms are permitted to be correlated. The system yields a coeffi-
cient on the treatment allocation term in both equations to enable
estimation of cost/outcome differences between groups and the
covariance between those coefficients.
To adjust for imbalances in cluster size, we incorporated a
treatment × cluster size interaction term into each equation
(Gomes et al., 2012b). Cost and outcome (QALY; dichotomous
6-month depression-risk) equations adjusted for potential con-
founders: mother’s age, history of PND, living alone, any history
of major life-events, baseline 6-week EPDS score, number of other
children in the family and whether mother was economically
active. In an analysis of the primary outcome, costs and QALY
equations additionally controlled for 6-week (baseline) utility
(Manca et al., 2005a). The impact of clustering on estimation pre-
cision was accounted for by calculating cluster-robust errors.
Incremental cost-effectiveness ratios (ICERs) and cost-
effectiveness acceptability curves (CEACs) were generated from
cost and outcome regressions. CEACs show the probability that
an intervention is cost-effective at various hypothetical ‘threshold
values’ of an outcome. The range of willingness-to-pay values
covered by the CEAC included £20 000 per QALY, the lower
range of thresholds typically used by NICE to identify which
interventions to recommend for implementation (National
Institute for Clinical Excellence, 2004; National Institute for
Health and Clinical Excellence, 2008; National Institute for
Health and Care Excellence, 2013). While women with complete
clinical and economic data (complete cases) were considered in
the base-case analysis, imputation of 6-month missing data was
carried out in sensitivity analyses.
Sensitivity analyses
To explore whether primary outcome (QALY) findings were
robust to assumptions in important parameters, we varied the
Table 1. Unit costs of resources used
Resource
Unit cost
(£s 2003/4) Source
HV hour of client
contact without
CBA/PCA training
77 Netten and Curtis (2004)
HV hour of client
contact with
CBA/PCA training
79 Study records (and using HV
contacts data from Table 2)
GP contacta 30 Netten and Curtis (2004)
Social work
visitb
108 Netten and Curtis (2004)
Clinical mental
health contactc,d
129 Trust Financial Returns 2004
(Department of Health, 2000)
Community
mental health
contacte
29 Netten and Curtis (2004)
Mother and baby
or psychiatric
unit dayc
458 Reference costs 2004 (Department
of Health, 2005)
Fluoxetine
prescriptionf
2 British National Formulary 2005
(British Medical Association and
Royal Pharmaceutical Society, 2011)
Other
prescriptiong
3 British National Formulary 2005
(British Medical Association and
Royal Pharmaceutical Society, 2011)
DTwP and Hib
vaccination per
dose
20 British National Formulary 2005
(British Medical Association and
Royal Pharmaceutical Society, 2011)
Men-C
vaccination per
dose
18 British National Formulary 2005
(British Medical Association and
Royal Pharmaceutical Society, 2011)
Inpatient
admission
(infant)c
516 Trust Financial Returns 2004
(Department of Health, 2000)
A&E attendancec 73 Reference costs 2004 (Department
of Health, 2005)
NHS direct
contact
25 Hansard (Hansard, 2004a, 2004b)
Walk-in centre
attendancec
39 Reference costs 2004 (Department
of Health, 2005)
aIncludes surgery, home and telephone contacts. Unit cost based on the most common type
of contact; surgery contact.
bAssuming a 2-hour visit. No information was available on length of visit.
cPrices adjusted using inflation indices given in Netten and Curtis, 2004. (Netten and Curtis,
2004).
dIncludes crisis service, psychologist, psychotherapist, psychiatric outpatient and mother
and baby psychiatric outpatient contacts. Unit cost based on the most common type of
contact; psychiatric outpatient contact.
eIncludes counsellor, community psychiatric nurse (CPN), community mental health team
(CMHT) and mental health nurse (MHN) contacts. Unit cost based on the most common type
of contact; CPN home visit.
fBased on most common drug and dosage for antidepressant prescriptions.
gCalculated as an average of the prescriptions for the eight most common indications.
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Table 2. Resource use at 6-months, available cases
Item
Control
Intervention
(combined)
Intervention
(CBA)
Intervention
(PCA) Intervention (combined) Intervention (CBA) Intervention (PCA)
Mean (S.E.)
n = 417
Mean (S.E.)
n = 1042
Mean (S.E.)
n = 553
Mean (S.E.)
n = 489
Mean difference from control
(95% confidence interval)
Mean difference from control
(95% confidence interval)
Mean difference from
control (95% confidence
interval)
HV total contactsa 8.0 (0.8) 6.4 (0.5) 6.7 (0.8) 6.1 (0.9) −1.6 (−3.5, 0.3) −1.3 (−3.7, 1.1) −1.9 (−4.4, 0.7)
HV contacts for
babya
7.2 (0.7) 6.1 (0.5) 6.4 (0.7) 5.7 (0.8) −1.2 (−2.9, 0.5) −0.8 (−2.9, 1.3) −1.6 (−3.7, 0.6)
HV contacts for
mothera
3.6 (0.5) 2.0 (0.3) 1.4 (0.4) 2.7 (0.5) −1.6 (−2.7, −0.4)** −2.1 (−3.5, −0.8)** −0.9 (−2.3, 0.5)
HV contacts for
PNDa
0.3 (0.1) 0.2 (0.1) 0.2 (0.1) 0.2 (0.1) −0.1 (−0.3, 0.1) −0.0 (−0.3, 0.2) −0.1 (−0.3, 0.1)
Total HV minutes 172.7 (20.7) 116.8 (13.6) 110.7 (20.3) 123.7 (23.8) −55.9 (−105.4, −6.5)* −62.1 (−123.9, −0.2)* −49.0 (−117.4, 19.4)
GP contacts 2.5 (0.2) 2.3 (0.1) 2.3 (0.2) 2.3 (0.2) −0.2 (−0.7, 0.3) −0.2 (−0.8, 0.4) −0.1 (−0.7, 0.5)
Mother and baby
unit days
0 0 0 0 0 0 0
Community mental
health contactsb
0 0 0 0 0 0 0
Clinical mental
health contactsc
0 0 0 0 0 0 0
A&E attendances 0 0 0 0 0 0 0
Social services
contactsd
0 0 0 0 0 0 0
Antidepressant
prescriptions
0.1 (0.0) 0 0 0 −0.0 (−0.1, 0.0) −0.0 (−0.1, 0.0) −0.0 (−0.1, 0.0)
Other prescriptions 1.3 (0.1) 1.3 (0.1) 1.3 (0.1) 1.4 (0.1) 0.1 (−0.3, 0.4) 0.0 (−0.3, 0.4) 0.1 (−0.3, 0.5)
Note: Means (cluster-adjusted standard errors and confidence intervals).
aNumber of baby, mother and PND visits sum to greater than the total number of visits due to some visits being for more than one purpose.
b5 or fewer contacts in the control and combined intervention groups. Means for both groups round to zero.
c5 or fewer contacts in the control and combined intervention groups; mean rounds to zero.
d5 or fewer contacts in the control group and combined intervention groups; mean rounds to zero.
*p < 0.05, **p < 0.01, ***p < 0.001.
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definition of threshold delineating groups of lower-risk and
at-risk women at 6 weeks, considering a cut-off for being at-risk
of 10 or more on EPDS and a cut-off of 13 or more
(Songoygard et al., 2012; Morrell et al., 2016). We also performed
SUR on a two-stage bootstrapped sample of cost and outcomes
data (1000 replications) to address potential issues of non-
normality in distributions of costs and outcomes (Gomes et al.,
2012a). Bootstrap sampling was stratified by randomised group.
The methods are presented as sensitivity analyses because one
caveat to using two-stage bootstrapping is lower-than-nominal
coverage probability (Gomes et al., 2012a). To examine the
impact of missing cases on 6-month results, we created ten com-
plete datasets generated by multilevel multiple-imputation mod-
els, and ran them separately for control and intervention groups
as previously recommended (Gomes et al., 2013). Models
included regressors used in the cost-effectiveness analyses and
other baseline factors that predicted missing data on costs and
outcomes (feeding method, receipt of benefits, the age of leaving
full-time education). Continuous variables were imputed by pre-
dictive mean-matching and dichotomous variables were imputed
by logistic regression. Multilevel imputation was implemented by
chained equations using the mice (Buuren and Groothuis-
Oudshoorn, 2011) and miceadds (Robitzsch et al., 2016) packages
in R statistical software (R Core Team, 2016). Results of the SUR
from each of the ten complete datasets were combined in Stata
using Rubin’s rules (Rubin, 1987; StataCorp, 2015).
Results
A total of 2241 lower-risk women (767 control in 37 clusters; 1474
intervention in 63 clusters) completed the EPDS at 6-month
follow-up. Data sufficient to compute SF-6D scores at both
6-week and 6-month time-points were available for 2158 partici-
pants (736 control in 37 clusters; 1422 intervention in 63 clusters).
There were 1459 women with complete economic and SF-6D data
at both time-points (417 control in 23 clusters; 1042 intervention
in 47 clusters). Participants’ baseline characteristics are sum-
marised in Supplementary Table S1.1 for the full lower-risk sam-
ple (N = 2241), the sample with economic data (N = 1459) and the
sample without economic data (N = 782). Baseline characteristics
of the samples with and without economic data within their
experimental groups differed in only one respect: at baseline,
3% (10/350) of control group women without economic data
available reported poor baby health over the previous 4 weeks
compared with 1% (3/417) of control group women with eco-
nomic data.
Resource use and costs
Over the 6-month period (Table 2), there were no A&E atten-
dances or admissions to mother and baby psychiatric units,
while clinical and community mental health contacts and social
services visits were extremely rare (five contacts or fewer in either
group). The intervention group had statistically significantly fewer
HV visits focused on the mother than the control group (3.6 v.
2.0, p < = 0.001), with similar results for PND visits (although
contacts for this reason, were comparatively low: 0.3 v. 0.2). HV
contacts that were focused on the mother differed between control
and combined (CBA/PCA) intervention sub-groups (3.6 v. 1.4,
p = 0.003). Overall, total HV time spent with the mother/baby
was 56 minutes lower in the intervention than control group
(p = 0.027). Average time spent by HVs in the CBA subgroup
was 62 minutes lower ( p = 0.049) than in the control group.
Average time spent by HVs in the PCA subgroup was not differ-
ent from that in the control group ( p = 0.156).
Initial bivariate analyses examining a number of visits to
women in the ‘very low risk’ and ‘subthreshold risk’ groups
showed interesting patterns. Mean number of visits related to
mother’s health, and for PND specifically, appeared to rise as
EPDS score rose (online Supplementary Table S2.1). This pattern
was not seen in visits related to baby health. A number of visits
related to the mother’s health was significantly lower in the
CBA group compared with control group, and also in the CBA
and the PCA groups combined compared to control, for both
‘very low risk’ and ‘subthreshold risk’ women. Visits were some-
what but not significantly lower in the PCA group compared with
controls within sub-groups.
Further multivariate analyses examined the impact of the
PoNDER HV training on the total number of HV visits (for all
purposes). In the lower-risk sample, intervention participants
received non-significantly more visits than controls (online
Supplementary Table S3.1); results were quite similar for CBA
and PCA approaches. Analyses also examined whether the inter-
vention had a differential impact on a number of HV visits
according to how near mothers’ EPDS scores were to 12.
Intervention participants in both subthreshold risk and very low-
risk groups received (non-significantly) more HV visits than con-
trols, similar to the results over the whole lower-risk sample. The
interaction term for combined intervention and risk sub-group
was not significantly different from zero (p = 0.905); results
were similar for CBA and PCA (p = 0.837 and p = 0.647, respect-
ively). The impact of the intervention appears to have been rela-
tively uniform over the whole of the lower-risk sample.
The overall cost of care for women in the intervention group
was significantly lower (difference of £72; 95% CI −137 to −8;
cluster-adjusted t = 2.246, p = 0.028) than for controls (Table 3).
Outcomes
Control and intervention groups were similar in terms of baseline
(6-week) utilities (Table 4); utilities were somewhat higher in the
intervention group at 6 months. Mean QALYs were significantly
higher in the combined intervention group than in controls
(mean difference: 0.004 95% CI 0.000–0.008, p = 0.0466). There
was a 2.8% difference (95% CI −0.5% to 6.1%) in the proportions
remaining at low risk at 6 months between the combined CBA
and PCA intervention and control groups.
Clustering and correlation of costs and outcomes data
ICCs of QALYs (online Supplementary Table S4.1) were negative
and larger in the control group than in the combined intervention
group; ICCs for costs were higher in the combined intervention
group than in the control group. Mean cluster sizes differed
between control (18.1) and intervention groups (22.2). Taking
Cohen’s criterion (Cohen, 1988) as a gauge of effect size, costs
were moderately positively correlated with cluster size in the con-
trol group (r = 0.43, p⩽ 0.001) and weakly negatively correlated
with cluster size in the CBA group (r =−0.20, p⩽ 0.001);
QALYs were weakly positively correlated with cluster size in the
CBA (r = 0.09, p = 0.030) and weakly negatively correlated with
cluster size in the PCA groups (r = −0.03, p = 0.005); but not cor-
related when these intervention groups were combined. These
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results indicate the need to adjust appropriately for both cluster-
ing and correlation within the cost-effectiveness analyses.
Results of the cost-effectiveness analyses
The inclusion of covariates with small amounts of missing data
slightly decreased the sample available for analysis to 1446
(with the loss of 7/1035 (0.8%) intervention cases and 6/411
(1.4%) controls).
Outcomes
Mean QALY difference between intervention and control groups,
adjusted for covariates, was not statistically significant (Table 5).
Results are similar for the intervention subgroups, although
gains were slightly greater in the CBA than PCA group. For the
dichotomised risk of depression outcome, the adjusted difference
in the proportions of mothers at low-risk at 6 months was very
slightly lower than the unadjusted figures for the combined inter-
vention groups and for CBA and PCA separately.
Costs and cost-effectiveness
Adjusted 6-month costs in the intervention group were £82 lower
than in the controls. In the intervention sub-groups, costs in the
CBA group were £93 lower and costs in the PCA group £73 lower
compared with controls.
The point estimate for the cost of a QALY created by the inter-
vention was negative. A negative ICER may occur when costs are
lower and outcomes better in one group (referred to as ‘domin-
ance’). In this case, because outcomes were approximately equiva-
lent between groups, although costs were significantly lower in the
intervention group, the resulting confidence intervals of the ICER
were wide, crossing zero and the upper bound was less than the
lower bound (Glick et al., 2007). We can take from the results
that the PoNDER intervention is the preferred strategy over
usual care, as long as the NHS is willing to pay anywhere from
0 to approximately £66 500 per QALY. The probability of the
intervention being cost-effective at £20 000 exceeds 99% (Fig. 1).
When looking at the CEACs for CBA v. control and PCA v.
control, there was little difference between them in the probability
of being cost-effective (over 99%) over the range of QALY values
between 0 and £20 000 (Fig. 2). CBA had a marginally higher
probability of cost-effectiveness, which reflects the slightly lower
mean costs of CBA, with similar QALYs gained between all
three strategies.
The cost of being in the lower-risk group at 6 months rather
than in the at-risk group as a result of the intervention (the
ICER) was very low, at about £3500.
Sensitivity analyses
Results of all sensitivity analyses are given in Supplementary
Table S5.1.
To examine whether results are robust to violations of the
assumption of normally distributed dependent variables, the
regressions were applied to data generated by two-stage bootstrap-
ping. There was a 99% probability that the intervention was cost-
Table 3. Costs at 6-months (£), available cases
Item
Control
Intervention
(combined)
Intervention
(CBA)
Intervention
(PCA)
Intervention
(combined)
Intervention
(CBA)
Intervention
(PCA)
Mean
(S.E.)
n = 417
Mean (S.E.)
n = 1042
Mean (S.E.)
n = 553
Mean (S.E.)
n = 489
Mean difference
from control
(95% confidence
interval)
Mean difference
from control
(95% confidence
interval)
Mean
difference from
control (95%
confidence
interval)
HV contacts 222 (27) 154 (18) 146 (26) 163 (31) −68 (−132, −4)* −76 (−156, 4) −59 (−147, 30)
GP contacts 74 (6) 69 (4) 68 (6) 70 (6) −5 (−21,10) −6 (−24, 11) −4 (−22, 14)
Mother and
baby unit
admissions
0 0 0 0 0 0 0
Community
mental health
contacts
0 0 0 0 0 0 0
Clinical mental
health contacts
0 (1) 1 (0) 0 1 (1) 1 (−1, 2) 0 1 (−1, 4)
A&E
attendances
0 0 0 0 0 0 0
Social services
contacts
0 0 0 0 0 0 (−0, 1) 0
Antidepressant
prescriptions
0 0 0 0 −0 −0 −0
Other
prescriptions
4 (0) 4 (0) 4 (0) 4 (0) 0 (−1, 1) 0 (−1, 1) 0 (−1,1)
Total cost 300 (27) 227 (18) 218 (27) 238 (31) −72 (−137, −8)* −82 (−163, −1)* −61 (−149, 27)
Note: Means (cluster-adjusted standard errors and confidence intervals).
*p < 0.05.
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Table 4. Outcome measures in the sample of cases available for cost-effectiveness analyses
Item
Control
Intervention
(combined)
Intervention
(CBA)
Intervention
(PCA) Intervention (combined) Intervention (CBA) Intervention (PCA)
Mean (S.E.)
n = 411
Mean (S.E.)
n = 1035
Mean (S.E.)
n = 548
Mean (S.E.)
n = 487
Mean difference from control
(95% confidence interval)
Mean difference from control
(95% confidence interval)
Mean difference from control
(95% confidence interval)
6 week utility 0.679 (0.004) 0.685 (0.003) 0.685 (0.004) 0.685 (0.004) 0.006 (−0.004, 0.016) 0.006 (−0.005, 0.017) 0.006 (−0.005, 0.018)
6 month
utility
0.831 (0.007) 0.846 (0.004) 0.846 (0.007) 0.846 (0.006) 0.015 (−0.002, 0.031) 0.015 (−0.006, 0.036) 0.015 (−0.003, 0.032)
QALY 0.290 (0.002) 0.294 (0.001) 0.294 (0.002) 0.294 (0.002) 0.004 (0.000, 0.008)* 0.004 (−0.001, 0.009) 0.004 (−0.001, 0.009)
Low-risk
status at 6
monthsa
89.1% (1.4%) 91.9% (0.9%) 92.0% (1.3%) 91.8% (1.3%) 2.8% (−0.5%, 6.1%) 2.9% (−01.2, 7.0%) 2.7% (−1.2%, 6.7%)
Note: Means (cluster-adjusted standard errors and confidence intervals).
aBinary variable representing whether the participant was at risk of depression, where EPDS⩾12 is coded as 0 and EPDS<12 is coded as 1. The variable is here treated as continuous, and results are expressed in percentage terms.
*p < 0.05.
Table 5. Cost-effectiveness analyses: costs, outcomes and ICERs at 6-months
Item
Group meansa (S.E.) Adjusted estimates (Mean difference from control) (95% CI)
Control
Intervention
(combined)
Intervention
(CBA)
Intervention
(PCA) Intervention (combined) Intervention (CBA) Intervention (PCA)
n = 411 n = 1035 n = 548 n = 487 n = 1446 n = 1446 n = 1446
QALYb 0.292 (0.001) 0.294 (0.001) 0.294 (0.001) 0.294 (0.001) 0.002 (−0.001,0.004) 0.002 (−0.001,0.005) 0.001 (−0.001,0.004)
Costsc 311 (23) 229 (12) 218 (12) 238 (19) −82** (−133, −31) −93*** (−143, −43) −73* (−131, −16)
ICERd – – – – −50 800 (66 500, −14 000) −52 800 (53 000, −15 500) −48 900 (50 000, −8 000)
Low-risk status at 6
monthse
89.4% (1.2%) 91.7% (0.8%) 92.0% (1.2%) 91.4% (0.9%) 2.3% (−1%, 5%) 2.6% (−0.9%, 6%) 2.0% (−1.1%, 5%)
ICERd – – – – −3 500 (13 800, −1000) −3 600 (unb’d, unb’d) −3 700 (unb’d, unb’d)
Note: unb’d = unbounded.
aEstimated marginal means, cluster-robust standard errors.
bEstimates from SUR equation for QALY adjusted for mother’s age, history of PND, living arrangement (alone or with others), any history of major life events, baseline EPDS score, number of other children in the family, whether the mother was
economically active, baseline utility.
cEstimates from SUR equation for costs adjusted for mother’s age, history of PND, living arrangement (alone or with others), any history of major life events, baseline EPDS score, number of other children in the family, whether the mother was
economically active, baseline utility.
dRounded to nearest 100.
eBinary variable representing whether the participant was at risk of depression, where EPDS⩾12 is coded as 0 and EPDS<12 is coded as 1. The variable is here treated as continuous, and results are expressed in percentage terms. Estimates from SUR
equation for low-risk at 6 month adjusted for mother’s age, history of PND, living arrangement (alone or with others), any history of major life events, baseline EPDS score, number of other children in the family, whether the mother was economically
active.
*p < 0.05, **p < 0.01, ***p < 0.01.
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effective at a willingness-to-pay of £20 000 (online Supplementary
file S1 Figure S1.1). Results for CBA and PCA were similar, CBA
having a 1% higher probability of cost-effectiveness at the £20 000
threshold (99% v. 98%).
We varied the cut-off score for the lower-risk sample (consid-
ering both a lower cut-off for being at-risk of 10 or more on the
EPDS and a higher cut-off of 13 or more on the EPDS) to exam-
ine whether the results were robust to changes in the size and
composition of the lower-risk group. The estimates of cost and
QALY differences were fairly similar to those in the main ana-
lyses. With the lower cut-off for higher-risk status, adjusted
QALY difference estimates were 0.001 (95% CI −0.002 to 0.004)
lower than in the main analyses (0.001 v. 0.002). With the higher
cut-off, estimates were the same as in the main analyses. Cost
differences were again similar to the main analyses for the
lower cut-off and £10 lower than in the main analyses with the
higher cut-off. CEACs were similar to those in the main analyses
(online Supplementary file S1 Figure S1.2).
Running the analyses on imputed data also produced similar
results to the main analyses in terms of estimated mean costs
and QALYs at 6 months. The adjusted QALY difference was
very slightly higher than in the main analysis and the confidence
interval did not cross zero; the adjusted cost difference of −£47
(95% CI −85 to −10) was £35 lower than in the main analysis,
with a smaller confidence interval. The ICER was considerably
reduced (from −50 800 to −16 700), with a confidence interval
that was negative, suggesting that, taking sampling uncertainty
into account as well as the point estimate, the combined
Fig. 1. Cost-effectiveness acceptability curve: QALY.
Fig. 2. Cost-effectiveness acceptability curve: dichotomous
variable for low-risk of PND at 6 months.
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intervention was dominant. CEACs were very similar to those in
the main analyses (online Supplementary file S1 Figure S1.3).
Discussion
Our analyses examined the impacts of PoNDER HV training
package on 6-month costs and QALYs for mothers at lower risk
of PND. The intervention for this population of mothers was
not only cost-effective at the NICE threshold of £20 000 per
QALY gained, but also cost-reducing. This finding is of particular
interest given that the eight psychologically-informed HV sessions
were primarily targeted at women with an EPDS score of 12 or
more (Morrell et al., 2009b; Brugha et al., 2011) and not at
those ‘very low risk’ and ‘subthreshold risk’ women included in
the analyses reported here. The choice of approach (CBA or
PCA) made relatively little difference to cost or to the probability
of cost-effectiveness at the £20 000 threshold, suggesting that
training in CBA and PCA approaches had more or less equivalent
economic consequences. The impact of PoNDER HV training did
not appear to be confined to those women closer to the EPDS
threshold score of 12, as evidenced by analyses of a number of
HV visits across risk sub-groups and by sensitivity analyses
varying the threshold for lower-risk.
In relation to the secondary outcome, the 2.3% mean differ-
ence between intervention and control groups in proportions of
lower-risk women at 6 months was not statistically significant.
In analyses elsewhere of a larger sample of lower-risk women
(N = 2241) than the 1446 observations available for the economic
analysis, the percentage of women with an EPDS score of 12 or
more 6-months postnatally was 10.8% of control women and
7.7% of intervention women, a difference of 3.1% (95% CI 0.4–
5.9%) (Morrell et al., 2009a; Brugha et al., 2011). Nonetheless,
in the economic evaluation sample, the probability of cost-
effectiveness was very high over a range of willingness-to-pay
thresholds below £14 000 for being lower-risk rather than at-risk
at 6 months.
These findings provide strong evidence that the training pro-
gramme was cost-effective in preventing depression 6 months
after childbirth in mothers at lower risk of depression even though
psychological intervention sessions were not targeted on them
(Brugha et al., 2011). This intervention reduced the risk of
depression and paid for itself over 6 months.
We also found that the number of visits related to the
mother’s health was significantly lower in the combined inter-
vention group compared with controls. After the training, the
intervention groups HVs were more confident in assessing
risk and reassessing women than the control group HVs
(Morrell et al., 2009b). The HVs offered face-to-face psycho-
logical support sessions to women who were indicated as
depressed according to their clinical assessment and face-to-face
EPDS score. The HVs could distinguish true depression from
extreme tiredness and labile mood. Therefore, the intervention
group HVs appropriately responded to all levels of risk accord-
ing to the combination of the EPDS score and enhanced clinical
assessment skills gained during the training. This may have
made them more efficient in their visits to those women at
greater risk rather than to those at less risk in comparison
with the control groups. In contrast, control group HVs were
not trained to have the skills to know which women were
truly depressed and therefore may have visited those women
who had extreme tiredness and some symptoms of depression
but were not depressed.
Strengths and limitations
Strengths of the study include a large number of observations
available for analysis, analytic methods appropriate to clustered
data and sensitivity analyses of key assumptions in those analyses.
The purpose of cluster allocation in training interventions is to
protect against contamination of the untrained control group; dis-
advantages of this approach include potential selection biases dur-
ing recruitment, increased complexity of design and increased
sample sizes required compared with individual randomisation
(Klar, 2015). Cluster allocation also ensured that health outcomes
related to all HVs within each cluster, thereby strengthening the
generalisability of results. Our analyses addressed imbalances
between trial arms in terms of numbers and size of clusters, an
issue not considered in the original analyses (Morrell et al.,
2009b). Other potential challenges to the robustness of results
(impacts of missing cost data and skewness of dependent vari-
ables) were explored in sensitivity analyses; they did not make
any difference to the conclusions drawn from the main analyses.
There were several limitations to this study. Data available for
the cost-effectiveness analysis were less complete than those avail-
able on health outcome data; however, sensitivity analyses draw-
ing on multiply-imputed data confirmed the findings, indicating
if anything even stronger evidence of the dominance of the inter-
vention over usual care.
Cost measures were confined to health and social care services,
a limitation when looking at women at lower risk of depression
who have less need for support. We only analysed costs over
6-months postnatally so we did not factor in the risk of longer-
term adverse effects on child development and associated costs
(Bauer et al., 2016b) or on employment-related productivity losses
associated with depression (Thomas and Morris, 2003).
Present-day unit costs may differ from those used here (2003/
04 prices) which reflect the organisation of care and mix of ser-
vices at the time of the trial. Organisation of care, outcomes
and unit costs were undoubtedly interrelated and cannot now
be easily disentangled. The organisation of health visiting has
changed over time: HVs are registered nurses or midwives who
can now gain additional qualifications to become specialist com-
munity public health nurses (Cowley et al., 2013; Health
Education England, 2016). There has been a national programme
to improve access to child health services, increasing numbers of
HVs, and to transfer the commissioning of health visiting to local
government (Department of Health, 2015). Such changes could
affect unit costs. The cost of an hour of health visiting
(client-related work) in 2014/15 was £76 (Curtis and Burns,
2015), whereas the hourly cost used here would be £101 if uprated
to 2014/15 prices (Curtis and Burns, 2015). Data sources and
methods used to estimate HV unit costs have changed since
2004 (Netten and Curtis, 2004), as no data on HV time-use was
available for later calculations (e.g. for face-to-face/indirect con-
tacts and travel) (Curtis and Burns, 2015).
Our cost-effectiveness analysis adopted methods consistent with
good practice guidelines (Ramsey et al., 2015) and employed meth-
ods relevant to clustered data, but the choice of analytical model can
influence results (Mantopoulos et al., 2016) and so is a source of
methodological uncertainty. However, given the strength of our
conclusions, such uncertainties are unlikely to be a concern.
In the base-case analysis, the mean utility scores of interven-
tion group mothers were not significantly greater than for control
group mothers. We might ask whether measurement of changes
in utility in mothers at lower risk for depression can be as accurate
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as in an at-risk population. However, the SF-6D is sensitive to dif-
ferences in EPDS scores, discriminating well between different
dichotomised levels of risk for PND (Petrou et al., 2009).
Implications for policy and practice
PoNDER HV training offers the benefit of a service delivered in
routine postnatal care with an assessment by HVs with whom
women are already in contact: it is a low-cost universal preventive
intervention. It reduces the risk of developing PND symptoms,
reduces health and social care service use over 6-months and is
cost-effective. Recent reviews on the cost-effectiveness of prevent-
ive and early interventions (Bauer et al., 2016a; Morrell et al.,
2016) suggest that to date there are no other reports of an eco-
nomic evaluation alongside a clinical trial to prevent perinatal
mental health problems. Decision models drawing on the eco-
nomic evidence have found that some interventions that address
mild or subthreshold symptoms (including PCA and
CBT-based universal approaches) are likely to be cost-effective
and in some cases also lead to cost savings (Morrell et al.,
2016). There is also evidence that assessment by trained profes-
sionals such as HVs can lead to better outcomes for postnatal
women including reduced risk of depression (Bauer et al.,
2016b; O’Connor et al., 2016).
Two major global challenges in relation to mental illness are
the ‘treatment gap’(Kohn et al., 2004) and ‘prevention gap’
(Jorm et al., 2017). Rates of undiagnosed and untreated PND
are particularly high (Bijl et al., 2003), yet many women with peri-
natal depression do not take up screening (Reay et al., 2011). One
implication of our study is that there need not be a ‘prevention
gap’: women at lower risk of depression would benefit from sup-
port by HVs additionally trained in assessment and psychological
support. A universal prevention programme of this kind would
come at no extra cost to the healthcare system; indeed it would
be cost-reducing. There are potential implications for women’s
perception of available support should they need it (Henderson
et al., 1981; Brugha et al., 1998): women with perinatal depression
can be fearful of accessing mental health services (Slade et al.,
2010), for instance worrying that their children will be taken
into care (Dolman et al., 2013; Megnin-Viggars et al., 2015).
Conclusion
Our analyses confirm that PoNDER HV training in assessment
for symptoms of PND plus the skills to provide a psychologically
informed intervention (CBA or PCA) is cost-effective, even when
additional psychological care is not indicated. This provides sup-
port for further investigation of the merits of a universal service
that includes extra HV training in clinical assessment and the
ability to offer psychological support if indicated.
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